Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Familial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects.

Bu F, Borsa N, Gianluigi A, Smith RJ.

Clin Dev Immunol. 2012;2012:370426. doi: 10.1155/2012/370426. Epub 2012 Nov 8. Review.

2.

Atypical hemolytic uremic syndrome.

Loirat C, Frémeaux-Bacchi V.

Orphanet J Rare Dis. 2011 Sep 8;6:60. doi: 10.1186/1750-1172-6-60. Review.

3.

Complement disorders and hemolytic uremic syndrome.

Joseph C, Gattineni J.

Curr Opin Pediatr. 2013 Apr;25(2):209-15. doi: 10.1097/MOP.0b013e32835df48a. Review.

4.

Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.

Bu F, Maga T, Meyer NC, Wang K, Thomas CP, Nester CM, Smith RJ.

J Am Soc Nephrol. 2014 Jan;25(1):55-64. doi: 10.1681/ASN.2013050453. Epub 2013 Sep 12.

5.

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.

Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G.

Clin J Am Soc Nephrol. 2010 Oct;5(10):1844-59. doi: 10.2215/CJN.02210310. Epub 2010 Jul 1.

6.

Atypical hemolytic uremic syndrome.

Kavanagh D, Goodship TH, Richards A.

Semin Nephrol. 2013 Nov;33(6):508-30. doi: 10.1016/j.semnephrol.2013.08.003. Review.

7.

Adult Post-Kidney Transplant Familial Atypical Hemolytic Uremic Syndrome Successfully Treated With Eculizumab: A Case Report and Literature Review.

Salameh H, Abu Omar M, Alhariri A, Kisra S, Qasem A, Abdulhak AB.

Am J Ther. 2016 Jul-Aug;23(4):e1110-5. doi: 10.1097/MJT.0000000000000133.

PMID:
25486517
8.

Complement therapy in atypical haemolytic uraemic syndrome (aHUS).

Wong EK, Goodship TH, Kavanagh D.

Mol Immunol. 2013 Dec 15;56(3):199-212. doi: 10.1016/j.molimm.2013.05.224. Epub 2013 Jun 28. Review.

9.

Genetics and complement in atypical HUS.

Kavanagh D, Goodship T.

Pediatr Nephrol. 2010 Dec;25(12):2431-42. doi: 10.1007/s00467-010-1555-5. Epub 2010 Jun 6. Review.

10.

Posttransplant recurrence of atypical hemolytic uremic syndrome.

Valoti E, Alberti M, Noris M.

J Nephrol. 2012 Nov-Dec;25(6):911-7. doi: 10.5301/jn.5000146. Review.

PMID:
22760880
11.

Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.

Kavanagh D, Goodship TH.

Hematology Am Soc Hematol Educ Program. 2011;2011:15-20. doi: 10.1182/asheducation-2011.1.15.

PMID:
22160007
12.

Complement regulatory genes and hemolytic uremic syndromes.

Kavanagh D, Richards A, Atkinson J.

Annu Rev Med. 2008;59:293-309. Review.

PMID:
17705684
13.

Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.

Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ.

Hum Mutat. 2010 Jun;31(6):E1445-60. doi: 10.1002/humu.21256.

PMID:
20513133
14.

Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.

Provaznikova D, Rittich S, Malina M, Seeman T, Marinov I, Riedl M, Hrachovinova I.

Pediatr Nephrol. 2012 Jan;27(1):73-81. doi: 10.1007/s00467-011-1943-5. Epub 2011 Jun 27.

PMID:
21706448
15.

Genetics of atypical hemolytic uremic syndrome (aHUS).

Rodríguez de Córdoba S, Hidalgo MS, Pinto S, Tortajada A.

Semin Thromb Hemost. 2014 Jun;40(4):422-30. doi: 10.1055/s-0034-1375296. Epub 2014 May 5. Review.

PMID:
24799305
16.

Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.

Xie L, Nester CM, Reed AI, Zhang Y, Smith RJ, Thomas CP.

Transplant Proc. 2012 Dec;44(10):3037-40. doi: 10.1016/j.transproceed.2012.07.141.

PMID:
23195022
17.

Atypical hemolytic uremic syndrome: update on the complement system and what is new.

Hirt-Minkowski P, Dickenmann M, Schifferli JA.

Nephron Clin Pract. 2010;114(4):c219-35. doi: 10.1159/000276545. Epub 2010 Jan 14. Review.

18.

Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy.

Fakhouri F, Frémeaux-Bacchi V, Loirat C.

Eur J Intern Med. 2013 Sep;24(6):492-5. doi: 10.1016/j.ejim.2013.05.008. Epub 2013 Jun 5. Review.

PMID:
23756030
19.

Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.

Mache CJ, Acham-Roschitz B, Frémeaux-Bacchi V, Kirschfink M, Zipfel PF, Roedl S, Vester U, Ring E.

Clin J Am Soc Nephrol. 2009 Aug;4(8):1312-6. doi: 10.2215/CJN.01090209. Epub 2009 Jun 25.

20.

Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea.

Cheong HI, Jo SK, Yoon SS, Cho H, Kim JS, Kim YO, Koo JR, Park Y, Park YS, Shin JI, Yoo KH, Oh D.

J Korean Med Sci. 2016 Oct;31(10):1516-28. doi: 10.3346/jkms.2016.31.10.1516.

Supplemental Content

Support Center